Angela Cacace
Fortuna: 2 M $ al 31/05/2026
Fortuna: 2 M $ al 31/05/2026
Dr. Angela Cacace is a Chief Scientific Officer at Arvinas, Inc. Dr. Cacace was previously employed as a Neuroscience Director by Bristol Myers Squibb Co. She received her undergraduate degree from Fairfield University and a doctorate degree from The Trustees of Columbia University in The City of New York.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARVINAS, INC. 0,28 % | 17/06/2026 | 180.390 ( 0,28 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ARVINAS, INC. | Director Técnico/Científico/I+D | 17/06/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fairfield University
Fairfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arvinas, Inc.
Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.